MicroRNA miR-155 inhibits Bone Morphogenetic Protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation

Journal of Virology

Volumn 84, Issue 13, 2010, Pages 6318-6327

  Yin, Qinyan ^a   Wang, Xia ^a   Fewell, Claire ^a   Cameron, Jennifer ^a   Zhu, Hanqing ^a   Baddoo, Melody ^a   Lin, Zhen ^a   Flemington, Erik K ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 6; CYCLIN DEPENDENT KINASE INHIBITOR 1A; INHIBITOR OF DIFFERENTIATION 3; MICRORNA; OSTEOGENIC PROTEIN 1; PROTEIN CEBPB; SMAD1 PROTEIN; SMAD5 PROTEIN; TRANSCRIPTION FACTOR HIVEP2; TRANSCRIPTION FACTOR MYO10; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VIRUS DNA;

3' UNTRANSLATED REGION; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; CANCER INHIBITION; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VIRUS REACTIVATION; VIRUS SURVIVAL;

B-LYMPHOCYTES; BONE MORPHOGENETIC PROTEINS; CELL LINE; HERPESVIRUS 4, HUMAN; HUMANS; MICRORNAS; SIGNAL TRANSDUCTION; VIRUS ACTIVATION;

GALLID HERPESVIRUS 2; HERPESVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8;

EID: 77953308345     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00635-10     Document Type: Article

References (44)

1. Blanco Calvo, M., F. V. Bolos, V. V. Medina, G. G. Aparicio, P. S. Diaz, and P. E. Grande. 2009. Biology of BMP signaling and cancer. Clin. Transl. Oncol. 11:126-137.
2. Bleul, C. C., and T. Boehm. 2005. BMP signaling is required for normal thymus development. J. Immunol. 175:5213-5221. (Pubitemid 41456406)
3. Blitz, I. L., and K. W. Cho. 2009. Finding partners: how BMPs select their targets. Dev. Dyn. 238:1321-1331.
4. Buckley, S., W. Shi, B. Driscoll, A. Ferrario, K. Anderson, and D. Warburton. 2004. BMP4 signaling induces senescence and modulates the oncogenic phenotype of A549 lung adenocarcinoma cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 286:L81-L86.
5. Cameron, J. E., C. Fewell, Q. Yin, J. McBride, X. Wang, Z. Lin, and E. K. Flemington. 2008. Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Virology 382:257-266.
6. Cejalvo, T., R. Sacedon, C. Hernandez-Lopez, B. Diez, C. Gutierrez-Frias, J. Valencia, A. G. Zapata, A. Varas, and A. Vicente. 2007. Bone morphogenetic protein-2/4 signalling pathway components are expressed in the human thymus and inhibit early T-cell development. Immunology 121:94-104.
7. Clurman, B. E., and W. S. Hayward. 1989. Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: evidence for stage-specific events. Mol. Cell. Biol. 9:2657-2664.
8. Dorsett, Y., K. M. McBride, M. Jankovic, A. Gazumyan, T. H. Thai, D. F. Robbiani, M. Di Virgilio, B. R. San-Martin, G. Heidkamp, T. A. Schwickert, T. Eisenreich, K. Rajewsky, and M. C. Nussenzweig. 2008. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 28:630-638.
9. Eis, P. S., W. Tam, L. Sun, A. Chadburn, Z. Li, M. F. Gomez, E. Lund, and J. E. Dahlberg. 2005. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. U. S. A. 102:3627-3632.
10. Fukuda, M., W. Kurosaki, K. Yanagihara, H. Kuratsune, and T. Sairenji. 2002. A mechanism in Epstein-Barr virus oncogenesis: inhibition of transforming growth factor-beta 1-mediated induction of MAPK/p21 by LMP1. Virology 302:310-320.
11. Ghosh-Choudhury, N., K. Woodruff, W. Qi, A. Celeste, S. L. Abboud, and G. Ghosh Choudhury. 2000. Bone morphogenetic protein-2 blocks MDA MB 231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastoma protein phosphorylation. Biochem. Biophys. Res. Commun. 272:705-711.
12. Gottwein, E., N. Mukherjee, C. Sachse, C. Frenzel, W. H. Majoros, J. T. Chi, R. Braich, M. Manoharan, J. Soutschek, U. Ohler, and B. R. Cullen. 2007. A viral microRNA functions as an orthologue of cellular miR-155. Nature 450:1096-1099.
13. Hager-Theodorides, A. L., S. V. Outram, D. K. Shah, R. Sacedon, R. E. Shrimpton, A. Vicente, A. Varas, and T. Crompton. 2002. Bone morphogenetic protein 2/4 signaling regulates early thymocyte differentiation. J. Immunol. 169:5496-5504. (Pubitemid 35291647)
14. Inman, G. J., and M. J. Allday. 2000. Resistance to TGF-β1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines. J. Gen. Virol. 81:1567-1578.
15. Iorio, M. V., and C. M. Croce. 2009. MicroRNAs in cancer: small molecules with a huge impact. J. Clin. Oncol. 27:5848-5856.
16. Iorio, M. V., M. Ferracin, C. G. Liu, A. Veronese, R. Spizzo, S. Sabbioni, E. Magri, M. Pedriali, M. Fabbri, M. Campiglio, S. Menard, J. P. Palazzo, A. Rosenberg, P. Musiani, S. Volinia, I. Nenci, G. A. Calin, P. Querzoli, M. Negrini, and C. M. Croce. 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65:7065-7070.
17. Jiang, J., E. J. Lee, and T. D. Schmittgen. 2006. Increased expression of microRNA-155 in Epstein-Barr virus transformed lymphoblastoid cell lines. Genes Chromosomes Cancer 45:103-106.
18. Kersten, C., G. Dosen, J. H. Myklebust, E. A. Sivertsen, M. E. Hystad, E. B. Smeland, and E. Rian. 2006. BMP-6 inhibits human bone marrow B lymphopoiesis-upregulation of Id1 and Id3. Exp. Hematol. 34:72-81.
19. Kersten, C., E. A. Sivertsen, M. E. Hystad, L. Forfang, E. B. Smeland, and J. H. Myklebust. 2005. BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1. BMC Immunol. 6:9.
20. Kluiver, J., E. Haralambieva, D. de Jong, T. Blokzijl, S. Jacobs, B. J. Kroesen, S. Poppema, and A. van den Berg. 2006. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 45:147-153.
21. Kluiver, J., S. Poppema, D. de Jong, T. Blokzijl, G. Harms, S. Jacobs, B. J. Kroesen, and A. van den Berg. 2005. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol. 207:243-249.
22. Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.
23. Lu, F., A. Weidmer, C. G. Liu, S. Volinia, C. M. Croce, and P. M. Lieberman. 2008. Epstein-Barr virus-induced miR-155 attenuates NF-κB signaling and stabilizes latent virus persistence. J. Virol. 82:10436-10443.
24. Lu, J., G. Getz, E. A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B. L. Ebert, R. H. Mak, A. A. Ferrando, J. R. Downing, T. Jacks, H. R. Horvitz, and T. R. Golub. 2005. MicroRNA expression profiles classify human cancers. Nature 435:834-838.
25. Mayr, C., and D. P. Bartel. 2009. Widespread shortening of 3′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138:673-684.
26. Miller, C. L., J. H. Lee, E. Kieff, and R. Longnecker. 1994. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc. Natl. Acad. Sci. U. S. A. 91:772-776.
27. Miyazono, K., S. Maeda, and T. Imamura. 2005. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 16:251-263.
28. Morgan, R., A. Anderson, E. Bernberg, S. Kamboj, E. Huang, G. Lagasse, G. Isaacs, M. Parcells, B. C. Meyers, P. J. Green, and J. Burnside. 2008. Sequence conservation and differential expression of Marek's disease virus microRNAs. J. Virol. 82:12213-12220.
29. Motsch, N., T. Pfuhl, J. Mrazek, S. Barth, and F. A. Grasser. 2007. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol. 4:131-137.
30. Pi, X., R. Ren, R. Kelley, C. Zhang, M. Moser, A. B. Bohil, M. Divito, R. E. Cheney, and C. Patterson. 2007. Sequential roles for myosin-X in BMP6-dependent filopodial extension, migration, and activation of BMP receptors. J. Cell Biol. 179:1569-1582.
31. Rai, D., S. W. Kim, M. R. McKeller, P. L. Dahia, and R. C. Aguiar. 2010. Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc. Natl. Acad. Sci. U. S. A. 107:3111-3116.
32. Reynisdottir, I., K. Polyak, A. Iavarone, and J. Massague. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9:1831-1845.
33. Rodriguez, A., E. Vigorito, S. Clare, M. V. Warren, P. Couttet, D. R. Soond, S. van Dongen, R. J. Grocock, P. P. Das, E. A. Miska, D. Vetrie, K. Okkenhaug, A. J. Enright, G. Dougan, M. Turner, and A. Bradley. 2007. Requirement of bic/microRNA-155 for normal immune function. Science 316:608-611.
34. Sandberg, R., J. R. Neilson, A. Sarma, P. A. Sharp, and C. B. Burge. 2008. Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites. Science 320:1643-1647.
35. Schuster, C., S. Chasserot-Golaz, and G. Beck. 1991. Activation of Epstein-Barr virus promoters by a growth-factor and a glucocorticoid. FEBS Lett. 284:82-86.
36. Seoane, J., H. V. Le, L. Shen, S. A. Anderson, and J. Massague. 2004. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117:211-223.
37. Sivertsen, E. A., K. Huse, M. E. Hystad, C. Kersten, E. B. Smeland, and J. H. Myklebust. 2007. Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells. Eur. J. Immunol. 37:2937-2948.
38. Skalsky, R. L., M. A. Samols, K. B. Plaisance, I. W. Boss, A. Riva, M. C. Lopez, H. V. Baker, and R. Renne. 2007. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J. Virol. 81:12836-12845.
39. Tam, W., D. Ben-Yehuda, and W. S. Hayward. 1997. bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol. Cell. Biol. 17:1490-1502.
40. Teng, G., P. Hakimpour, P. Landgraf, A. Rice, T. Tuschl, R. Casellas, and F. N. Papavasiliou. 2008. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28:621-629.
41. Thai, T. H., D. P. Calado, S. Casola, K. M. Ansel, C. Xiao, Y. Xue, A. Murphy, D. Frendewey, D. Valenzuela, J. L. Kutok, M. Schmidt-Supprian, N. Rajewsky, G. Yancopoulos, A. Rao, and K. Rajewsky. 2007. Regulation of the germinal center response by microRNA-155. Science 316:604-608.
42. Volinia, S., G. A. Calin, C. G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R. L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C. C. Harris, and C. M. Croce. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103:2257-2261.
43. Yanaihara, N., N. Caplen, E. Bowman, M. Seike, K. Kumamoto, M. Yi, R. M. Stephens, A. Okamoto, J. Yokota, T. Tanaka, G. A. Calin, C. G. Liu, C. M. Croce, and C. C. Harris. 2006. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9:189-198.
44. Yin, Q., J. McBride, C. Fewell, M. Lacey, X. Wang, Z. Lin, J. Cameron, and E. K. Flemington. 2008. MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J. Virol. 82:5295-5306.